John R. Toomey
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Platelet Disorders and Treatments, Hemophilia Treatment and Research
Most-Cited Works
- → An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure(2012)328 cited
- → Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype(2013)151 cited
- → Effect of tissue factor deficiency on mouse and tumor development(1997)87 cited
- → Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function(2009)86 cited
- → Localization of the human tissue factor recognition determinant of human factor VIIa.(1991)85 cited
- → Antithrombotic Efficacy of a Novel Murine Antihuman Factor IX Antibody in Rats(1999)69 cited
- → Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke(2002)52 cited
- → An Inhibitory Anti-factor IX Antibody Effectively Reduces Thrombus Formation in a Rat Model of Venous Thrombosis(1999)51 cited
- → Factor Xa Inhibitors: S1 Binding Interactions of a Series of N-{(3S)-1-[(1S)-1-Methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides(2007)49 cited
- → The Factor IX γ-Carboxyglutamic Acid (Gla) Domain Is Involved in Interactions between Factor IX and Factor XIa(2003)49 cited